TuHURA Biosciences Net Worth

TuHURA Biosciences Net Worth Breakdown

  HURA
The net worth of TuHURA Biosciences is the difference between its total assets and liabilities. TuHURA Biosciences' net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of TuHURA Biosciences' assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. TuHURA Biosciences' net worth can be used as a measure of its financial health and stability which can help investors to decide if TuHURA Biosciences is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in TuHURA Biosciences stock.

TuHURA Biosciences Net Worth Analysis

TuHURA Biosciences' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including TuHURA Biosciences' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of TuHURA Biosciences' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform TuHURA Biosciences' net worth analysis. One common approach is to calculate TuHURA Biosciences' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares TuHURA Biosciences' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing TuHURA Biosciences' net worth. This approach calculates the present value of TuHURA Biosciences' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of TuHURA Biosciences' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate TuHURA Biosciences' net worth. This involves comparing TuHURA Biosciences' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into TuHURA Biosciences' net worth relative to its peers.

Enterprise Value

321.94 Million

To determine if TuHURA Biosciences is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding TuHURA Biosciences' net worth research are outlined below:
TuHURA Biosciences had very high historical volatility over the last 90 days
TuHURA Biosciences has a very high chance of going through financial distress in the upcoming years
TuHURA Biosciences was previously known as Kintara Therapeutics and was traded on NASDAQ Exchange under the symbol KTRA.
Net Loss for the year was (29.32 M) with profit before overhead, payroll, taxes, and interest of 0.
TuHURA Biosciences generates negative cash flow from operations
TuHURA Biosciences has a frail financial position based on the latest SEC disclosures
Latest headline from thelincolnianonline.com: TuHURA Biosciences Now Covered by Rodman Renshaw

Follow TuHURA Biosciences' market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 141.65 M.

Market Cap

587.5 Million

Project TuHURA Biosciences' profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(6.72)(6.39)
Return On Capital Employed(38.89)(36.94)
Return On Assets(6.72)(6.39)
Return On Equity 18.81  19.75 
When accessing TuHURA Biosciences' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures TuHURA Biosciences' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of TuHURA Biosciences' profitability and make more informed investment decisions.
Please note, the presentation of TuHURA Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, TuHURA Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of TuHURA Biosciences' management manipulating its earnings.
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific TuHURA Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on TuHURA Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases TuHURA Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
TuHURA Biosciences time-series forecasting models is one of many TuHURA Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary TuHURA Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

TuHURA Biosciences Earnings per Share Projection vs Actual

When determining whether TuHURA Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TuHURA Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tuhura Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tuhura Biosciences Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in TuHURA Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TuHURA Biosciences. If investors know TuHURA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TuHURA Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of TuHURA Biosciences is measured differently than its book value, which is the value of TuHURA that is recorded on the company's balance sheet. Investors also form their own opinion of TuHURA Biosciences' value that differs from its market value or its book value, called intrinsic value, which is TuHURA Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TuHURA Biosciences' market value can be influenced by many factors that don't directly affect TuHURA Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TuHURA Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if TuHURA Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TuHURA Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.